Koers Sirona Biochem Corp Toronto S.E.
Aandelen
SBM
CA82967M1005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 672K 493K 455K | Omzet 2023 | 34,78K 25,5K 23,53K | Marktkapitalisatie | 21,44 mln. 15,72 mln. 14,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,2 mln. -2,03 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,47 mln. -1,35 mln. | EV/omzet 2022 | 48,8 x |
Nettoschuld 2022 | 48,04K 35,23K 32,51K | Nettoschuld 2023 | 1,61 mln. 1,18 mln. 1,09 mln. | EV/omzet 2023 | 663 x |
K/w-verhouding 2022 |
-8,81
x | K/w-verhouding 2023 |
-8,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 89,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+0,04% | 12,16 mld. | |
+25,12% | 12,21 mld. | |
+26,04% | 11,94 mld. |